| Issue |
Title |
File |
| Vol 16, No 1 (2016) |
Targeting Cancer Stem Cells: Promises and Challenges |
(Eng)
|
|
Kuhlmann J., Hein L., Kurth I., Wimberger P., Dubrovska A.
|
| Vol 12, No 1 (2012) |
Targeting Cancer Using Fragment Based Drug Discovery |
(Eng)
|
|
P. Turnbull A., M. Boyd S.
|
| Vol 11, No 6 (2011) |
Targeting Cell Death and Survival Receptors in Hepatocellular Carcinoma |
(Eng)
|
|
Muntane J.
|
| Vol 10, No 10 (2010) |
Targeting Focal Adhesion Kinase in Neuroblastoma |
(Eng)
|
|
Gillory L., A. Beierle E.
|
| Vol 23, No 17 (2023) |
Targeting Glutamine Metabolism through Glutaminase Inhibition Suppresses Cell Proliferation and Progression in Nasopharyngeal Carcinoma |
(Eng)
|
|
Su C., Li M., Yang Y., Wang Z., Wang Q., Wang W., Ma X., Jie R., Chen H., Li X., Lu J.
|
| Vol 13, No 3 (2013) |
Targeting Heme for the Identification of Cytotoxic Agents |
(Eng)
|
|
Zhang S., Chen H., Webster J., S. Gerhard G.
|
| Vol 15, No 3 (2015) |
Targeting Mitochondrial Citrate Transport in Breast Cancer Cell Lines |
(Eng)
|
|
Ozkaya A., Ak H., Atay S., Aydin H.
|
| Vol 13, No 7 (2013) |
Targeting mTOR: Evaluating the Therapeutic Potential of Resveratrol for Cancer Treatment |
(Eng)
|
|
Wu Y., Liu F.
|
| Vol 10, No 2 (2010) |
Targeting Ovarian Cancer-Initiating Cells |
(Eng)
|
|
Murphy S.
|
| Vol 11, No 5 (2011) |
Targeting Phosphoinositide 3-Kinase Pathways in Pancreatic Cancer from Molecular Signalling to Clinical Trials |
(Eng)
|
|
Falasca M., Selvaggi F., Buus R., Sulpizio S., E. Edling C.
|
| Vol 23, No 19 (2023) |
Targeting PPARγ/ NF-κB Signaling Pathway by Britannin, a Sesquiterpene Lactone from Inula aucheriana DC., in Gastric Cancer |
(Eng)
|
|
Abdolmohammadi M., Roozbehani M., Hamzeloo-Moghadam M., Heidari F., Fallahian F.
|
| Vol 11, No 6 (2011) |
Targeting Receptor Tyrosine Kinase Pathways in Hepatocellular Carcinoma |
(Eng)
|
|
Wen Chong L., Anh Tuan Luu D., Tzen Jong C., Wei Ling Lam I., Huynh H., Wei Jie Ong R., Yi Qing Li P., Shean Lee S., Yang S.
|
| Vol 25, No 1 (2025) |
Targeting RSK2 in Cancer Therapy: A Review of Natural Products |
(Eng)
|
|
Wu T., Chen Z., Liu X., Wu X., Wang Z., Guo W.
|
| Vol 11, No 9 (2011) |
Targeting Sphingosine-1-Phosphate in Hematologic Malignancies |
(Eng)
|
|
E. Stevenson C., Takabe K., Nagahashi M., Milstien S., Spiegel S.
|
| Vol 11, No 9 (2011) |
Targeting Sphingosine-1-Phosphate Receptors in Cancer |
(Eng)
|
|
J. Watters R., Wang H., Sung S., P. Loughran T., Liu X.
|
| Vol 10, No 2 (2010) |
Targeting the Acute Myeloid Leukemia Stem Cells |
(Eng)
|
|
Krause A., Fontanari Krause L., Rego E.
|
| Vol 13, No 5 (2013) |
Targeting the Fibroblast Growth Factor Receptors for the Treatment of Cancer |
(Eng)
|
|
Lemieux S., Hadden M.
|
| Vol 16, No 10 (2016) |
Targeting the Folate Receptor: Effects of Conjugating Folic Acid to DOX Loaded Polymeric Micelles |
(Eng)
|
|
Elkhodiry M., Husseini G., Velluto D.
|
| Vol 23, No 13 (2023) |
Targeting the LINC00324/miR-16-5p/SEPT2 Signaling Cascade is Effective to Reverse Malignant Phenotypes in Glioblastoma |
(Eng)
|
|
Chen B., Lin P., Li N.
|
| Vol 13, No 7 (2013) |
Targeting the PI3K/Akt/mTOR Axis by Apigenin for Cancer Prevention |
(Eng)
|
|
Tong X., Pelling J.
|
| Vol 12, No 8 (2012) |
Targeting Tumor Ubiquitin-Proteasome Pathway with Polyphenols for Chemosensitization |
(Eng)
|
|
Shen M., Hang Chan T., Ping Dou Q.
|
| Vol 11, No 8 (2011) |
Targeting βIII-Tubulin in Glioblastoma Multiforme: From Cell Biology and Histopathology to Cancer Therapeutics |
(Eng)
|
|
D. Katsetos C., Draber P., Kavallaris M.
|
| Vol 15, No 1 (2015) |
Tea (Camellia sinensis (L.)): A Putative Anticancer Agent in Bladder Carcinoma? |
(Eng)
|
|
Conde V., Alves M., Oliveira P., Silva B.
|
| Vol 10, No 3 (2010) |
Telomere Maintenance as Therapeutic Target in Embryonal Tumours |
(Eng)
|
|
Shalaby T., Hiyama E., Grotzer M.
|
| Vol 11, No 10 (2011) |
TEM8 Targeted Cancer Therapy |
(Eng)
|
|
E. Frankel A., Carter C., Kuo S., Woo J., Mauldin J., Liu J.
|
| Vol 11, No 2 (2011) |
Texaphyrins: Tumor Localizing Redox Active Expanded Porphyrins |
(Eng)
|
|
F. Arambula J., Preihs C., Borthwick D., Magda D., L. Sessler J.
|
| Vol 16, No 1 (2016) |
The Alkylating-HDAC Inhibition Fusion Principle: Taking Chemotherapy to the Next Level with the First in Class Molecule EDO-S101 |
(Eng)
|
|
Mehrling T., Chen Y.
|
| Vol 13, No 1 (2013) |
The Anti-cancer Actions of Vitamin D |
(Eng)
|
|
Chiang K., C. Chen T.
|
| Vol 13, No 5 (2013) |
The Application of Fungal Beta-glucans for the Treatment of Colon Cancer |
(Eng)
|
|
Chen J., Zhang X.D., Jiang Z.
|
| Vol 15, No 7 (2015) |
The Applications of Targeting Anti-Cancer Agents in Cancer Therapeutics |
(Eng)
|
|
Sun G., Yang X., Yu Y., Zhao D.
|
| Vol 12, No 10 (2012) |
The Cancer Preventive Effects of Edible Mushrooms |
(Eng)
|
|
Xu T., B. Beelman R., D. Lambert J.
|
| Vol 23, No 12 (2023) |
The Cell Death and Signal Transduction Mechanisms in Colorectal Carcinogenesis: Recent Advances |
(Eng)
|
|
Kashyap M., Ved A., Yadav R., Singh A., Kushwaha M., Shukla K.
|
| Vol 12, No 2 (2012) |
The Chemistry of Bisphosphonates: From Antiscaling Agents to Clinical Therapeutics |
(Eng)
|
|
Widler L., Jahnke W., R. Green J.
|
| Vol 13, No 9 (2013) |
The Complexity of Aging: Cancer Risk Among Elderly People and Infectious Risk Among Those with Cancer |
(Eng)
|
|
Pinzone M., Berretta M., Doerr H., Nunnari G., Cacopardo B.
|
| Vol 23, No 17 (2023) |
The Cytotoxic and Anti-tumor Potential of Methanolic Extracts of Indian Marine Isolates in HCT116 Colorectal Cancer Cells |
(Eng)
|
|
A S., Sekar S., Kasinathan K., KN A.
|
| Vol 15, No 3 (2015) |
The Cytotoxic and Mechanistic Effects of Aaptamine on Hepatocellular Carcinoma |
(Eng)
|
|
Li Q., Zhang P., Wang P., Yu H., Sun F., Hu W., Wu W., Zhang X., Chen F., Chu Z., Zhang J., Chen S., Lin H.
|
| Vol 12, No 7 (2012) |
The Cytotoxic Effect of Emetine and CGP-74514A Studied with the Hollow Fiber Model and ArrayScan Assay in Neuroendocrine Tumors In Vitro |
(Eng)
|
|
E. Larsson D., B. Hassan S., Oberg K., Granberg D.
|
| Vol 16, No 12 (2016) |
The cytotoxic effect of GW843682X on nasopharyngeal carcinoma |
(Eng)
|
|
Hu Q., Chu Y., Hu W., Peng M., Song Q.
|
| Vol 14, No 6 (2014) |
The Design and Characterization of a Novel beta-casein Nano-vehicle Loaded with Platinum Anticancer Drug for Drug Delivery |
(Eng)
|
|
Divsalar A., Razmi M., Saboury A., Seyedarabi A.
|
| Vol 24, No 12 (2024) |
The Development of Organotin(IV) N-Ethyl-N-Benzyldithiocarbamate Complexes: A Study on Their Synthesis, Characterization, and Cytocidal Effects on A549 Cell Line |
(Eng)
|
|
Abd Aziz N.A., Awang N., Kamaludin N.F., Mohamad Anuar N.N., Hamid A., Chan K.M., Arshad S.
|
| Vol 25, No 8 (2025) |
The Dual Role of ADAMTS9-AS1 in Various Human Cancers: Molecular Pathogenesis and Clinical Implications |
(Eng)
|
|
He H., Yang J., Zhou Y., Zheng X., Chen L., Mao Z., Liao C., Li T., Liu H., Zhou G., Li H., Yuan C.
|
| Vol 23, No 14 (2023) |
The Effect of Iron Oxide Nanoparticles of Acalypha wilkesiana Ethyl Acetate Extract on Ehrlich Ascites Carcinoma Cells |
(Eng)
|
|
Moustafa A., Abd El-Hamid El-Damrany M., Youssef M.
|
| Vol 14, No 6 (2014) |
The Effect of Lycopene on the PI3K/Akt Signalling Pathway in Prostate Cancer |
(Eng)
|
|
Chen J., O'Donoghue A., Deng Y., Zhang B., Kent F., O'Hare T.
|
| Vol 13, No 2 (2013) |
The Effect of Quercetin on Doxorubicin Cytotoxicity in Human Breast Cancer Cells |
(Eng)
|
|
Li S., Li K., Zhang J., Dong Z.
|
| Vol 13, No 5 (2013) |
The Effects of β -Glucans on Dendritic Cells and Implications for Cancer Therapy |
(Eng)
|
|
Albeituni S.H., Yan J.
|
| Vol 13, No 5 (2013) |
The Effects of β-glucans on Cancer Metastasis |
(Eng)
|
|
Yoon T.J., Koppula S., Lee K.H.
|
| Vol 24, No 16 (2024) |
The Growth Inhibitory Effect of Resveratrol and Gallic Acid on Prostate Cancer Cell Lines through the Alteration of Oxidative Stress Balance: The Interplay between Nrf2, HO-1, and BACH1 Genes |
(Eng)
|
|
Moghadam D., Zarei R., Rostami A., Samare-Najaf M., Ghojoghi R., Savardashtaki A., Jafarinia M., Vakili S., Irajie C.
|
| Vol 11, No 9 (2011) |
The Gut-To-Breast Connection - Interdependence of Sterols and Sphingolipids in Multidrug Resistance and Breast Cancer Therapy |
(Eng)
|
|
Spassieva S., Bieberich E.
|
| Vol 16, No 1 (2016) |
The Immune System in Cancer Prevention, Development and Therapy |
(Eng)
|
|
Candeias S., Gaipl U.
|
| Vol 14, No 2 (2014) |
The Immunomodulation and Anti-Inflammatory Effects of Garlic Organosulfur Compounds in Cancer Chemoprevention |
(Eng)
|
|
Schäfer G., Kaschula C.
|
| Vol 24, No 15 (2024) |
The Importance of Structural Water in HDAC8 for Correct Binding Pose Applied for Drug Design of Anticancer Molecules |
(Eng)
|
|
Morales-Herrejón G., Mendoza-Figueroa H., Martínez-Archundía M., Correa-Basurto J.
|
| Vol 14, No 6 (2014) |
The Indolylcoumarin COUFIN Exhibits Potent Activity Against Renal Carcinoma Cells without Affecting Hematopoietic System |
(Eng)
|
|
Champelovier P., Barbier P., Daras E., Douillard S., Toussaint B., Persoon V., Curri V., Peyrot V., Combes S.
|
| Vol 24, No 11 (2024) |
The Inhibitory Effects of Propofol on Colorectal Cancer Progression through the NF-κB/HIF-1α Signaling Pathway |
(Eng)
|
|
Yao L., Zhai W., Jiang Z., He R., Xie W., Li Y., Hu Y.
|
| Vol 14, No 1 (2014) |
The Interaction Between FAK, MYCN, p53 and Mdm2 in Neuroblastoma |
(Eng)
|
|
Waters A., Beierle E.
|
| Vol 14, No 1 (2014) |
The Interaction Between FAK, MYCN, p53 and Mdm2 in Neuroblastoma |
(Eng)
|
|
Waters A., Beierle E.
|
| Vol 14, No 10 (2014) |
The Interactions of Anticancer Agents with Tea Catechins: Current Evidence from Preclinical Studies |
(Eng)
|
|
Shang W., Lu W., Han M., Qiao J.
|
| Vol 10, No 8 (2010) |
The Interactions of Anti-Cancer Drugs Approved in the Last Decade in the United States with Membrane Transporters |
(Eng)
|
|
Jain L., Abraham S., S. Shord S.
|
| Vol 25, No 15 (2025) |
The Kinesin Eg5 Inhibitor K858 Enhances Radiosensitivity in Esophageal Squamous Cell Carcinoma and Affects the Expression of Epithelial-mesenchymal Transition Related Markers: In vitro and In vivo Studies |
(Eng)
|
|
Liu R., Yu Z., Shen W., Zhu S.
|
| Vol 14, No 4 (2014) |
The Membrane-targeted Alkylphosphocholine Erufosine Interferes with Survival Signals from the Extracellular Matrix |
(Eng)
|
|
Chometon G., Cappuccini F., Raducanu A., Aumailley M., Jendrossek V.
|
| Vol 25, No 6 (2025) |
The Mesoionic 1,3,4-thiadiazolium Derivative, MI-D, is a Potential Drug for Treating Glioblastoma by Impairing Mitochondrial Functions Linked to Energy Provision in Glioma Cells |
(Eng)
|
|
Corrêa-Ferreira M., do Rocio Andrade Pires A., Miranda J., de Freitas Montin E., Barbosa I., Lima A.E., Rocha M., Martinez G., Cadena S.M.
|
| Vol 14, No 1 (2014) |
The Microarray Gene Profiling Analysis of Glioblastoma Cancer Cells Reveals Genes Affected by FAK Inhibitor Y15 and Combination of Y15 and Temozolomide |
(Eng)
|
|
Huang G., Ho B., Conroy J., Liu S., Qiang H., Golubovskaya V.
|
| Vol 14, No 1 (2014) |
The Microarray Gene Profiling Analysis of Glioblastoma Cancer Cells Reveals Genes Affected by FAK Inhibitor Y15 and Combination of Y15 and Temozolomide |
(Eng)
|
|
Huang G., Ho B., Conroy J., Liu S., Qiang H., Golubovskaya V.
|
| Vol 14, No 2 (2014) |
The Need for Improvement of the Treatment of Advanced and Metastatic Cervical Cancer, the Rationale for Combined Chemo-Immunotherapy |
(Eng)
|
|
Meir H., Kenter G., Burggraaf J., Kroep J., Welters M., Melief C., Burg S., Poelgeest M.
|
| Vol 12, No 9 (2012) |
The Nuclear Orphan Receptors NR4A as Therapeutic Target in Cancer Therapy |
(Eng)
|
|
J. A. Deutsch A., Angerer H., E. Fuchs T., Neumeister P.
|
| Vol 24, No 15 (2024) |
The Potential Anticancer Potency of Kolaviron on Colorectal Adenocarcinoma (Caco-2) Cells |
(Eng)
|
|
Althagafi H.
|
| Vol 14, No 5 (2014) |
The Potential of Acridine Carboxamide Pt Complexes as Anti-Cancer Agents : A Review |
(Eng)
|
|
Murray V., Chen J., Galea A.
|
| Vol 10, No 7 (2010) |
The Potential of Tetrandrine Against Gliomas |
(Eng)
|
|
Chen Y., Tseng S.
|
| Vol 11, No 2 (2011) |
The Potential of Zn(II) N-Alkylpyridylporphyrins for Anticancer Therapy |
(Eng)
|
|
Benov L., Craik J., Batinic-Haberle I.
|
| Vol 24, No 16 (2024) |
The Potential Role of Non-coding RNAs in Regulating Ferroptosis in Cancer: Mechanisms and Application Prospects |
(Eng)
|
|
Cao M., Zhang Z., Hou X., Wang X.
|
| Vol 11, No 8 (2011) |
The Rationale of Targeting Neutrophils with Dapsone during Glioblastoma Treatment |
(Eng)
|
|
E. Kast R., Scheuerle A., R. Wirtz C., Karpel-Massler G., Halatsch M.
|
| Vol 13, No 5 (2013) |
The Role of Autophagic Cell Death and Apoptosis in Irinotecan-treated p53 Null Colon Cancer Cells |
(Eng)
|
|
John S., Mls J., Cervinka M., Rudolf E.
|
| Vol 12, No 6 (2012) |
The Role of Cdc25A in the Regulation of Cell Proliferation and Apoptosis |
(Eng)
|
|
Shen T., Huang S.
|
| Vol 25, No 19 (2025) |
The Role of Cisplatin Prodrugs Bonded to Polymer Carriers for Nanodrug-targeted Treatment of In situ Hepatocellular Carcinoma |
(Eng)
|
|
Li Z., Luo L., Wang Z., Hou J.
|
| Vol 13, No 4 (2013) |
The Role of Focal Adhesion Kinase in Lung Cancer |
(Eng)
|
|
K. Dy G.
|
| Vol 13, No 2 (2013) |
The Role of Mesothelin in Tumor Progression and Targeted Therapy |
(Eng)
|
|
Tang Z., Qian M., Ho M.
|
| Vol 12, No 9 (2012) |
The Role of Peroxisome Proliferator-Activated Receptor-γ in Breast Cancer |
(Eng)
|
|
Kotta-Loizou I., Giaginis C., Theocharis S.
|
| Vol 13, No 8 (2013) |
The Role of Phenolic Compounds in the Fight against Cancer A Review |
(Eng)
|
|
Carocho M., Ferreira I.
|
| Vol 24, No 18 (2024) |
The Role of Serine Protease 8 in Mediating Gefitinib Resistance in Non-small Cell Lung Cancer |
(Eng)
|
|
Gao H., Geng X., Wang L., Zhao C., Liang Z., Xing E.
|
| Vol 12, No 3 (2012) |
The Sequence Specificity of the Anti-tumour Drug, Cisplatin, in Telomeric DNA Sequences Compared with Consecutive Guanine DNA Sequences |
(Eng)
|
|
Murray V., Kandasamy N.
|
| Vol 12, No 3 (2012) |
The Stem Cell Niche as a Pharmaceutical Target for Prevention of Skeletal Metastases |
(Eng)
|
|
M. Chirgwin J.
|
| Vol 13, No 2 (2013) |
The Therapeutical Potential of a Novel Pterocarpanquinone LQB-118 to Target Inhibitor of Apoptosis Proteins in Acute Myeloid Leukemia Cells |
(Eng)
|
|
R. de Souza Reis F., C. Casal de Faria F., P. Castro C., S. de Souza P., da Cunha Vasconcelos F., D. Bello R., J. da Silva A., R.R. Costa P., C. Maia R.
|
| Vol 10, No 1 (2010) |
The Type II Transmembrane Serine Protease, Matriptase-2: Possible Links to Cancer? |
(Eng)
|
|
Sanders A., Webb S., Parr C., Mason M., Jiang W.
|
| Vol 11, No 2 (2011) |
The Ubiquitin+Proteasome Protein Degradation Pathway as a Therapeutic Strategy in the Treatment of Solid Tumor Malignancies |
(Eng)
|
|
J. Driscoll J., Minter A., A. Driscoll D., K. Burris J.
|
| Vol 15, No 6 (2015) |
The Use of Anthracyclines for Therapy of CNS Tumors |
(Eng)
|
|
Ros M., Iorio A., Lucchesi M., Stival A., Martino M., Sardi I.
|
| Vol 13, No 5 (2013) |
The Use of Lentinan for Treating Gastric Cancer |
(Eng)
|
|
Ina K., Kataoka T., Ando T.
|
| Vol 10, No 3 (2010) |
The Vitamin D/CYP24A1 Story in Cancer |
(Eng)
|
|
N. King A., G. Beer D., J. Christensen P., U. Simpson R., Ramnath N.
|
| Vol 10, No 6 (2010) |
Therapeutic Exploitation of Apoptosis and Autophagy for Glioblastoma |
(Eng)
|
|
Kogel D., Fulda S., Mittelbronn M.
|
| Vol 11, No 6 (2011) |
Therapeutic Potential of Targeting Glypican-3 in Hepatocellular Carcinoma |
(Eng)
|
|
Allegretta M., Filmus J.
|
| Vol 16, No 1 (2016) |
Therapeutic Potential of Targeting PAK Signaling |
(Eng)
|
|
Senapedis W., Crochiere M., Baloglu E., Landesman Y.
|
| Vol 11, No 8 (2011) |
Therapeutic Strategies to Target Multiple Kinases in Glioblastoma |
(Eng)
|
|
Sathornsumetee S.
|
| Vol 14, No 8 (2014) |
Therapeutic Targeting of Malignant Glioma |
(Eng)
|
|
Alexandru-Abrams D., Jadus M., Hsu F., Stathopoulos A., Bota D.
|
| Vol 16, No 1 (2016) |
Therapeutic Use of MicroRNAs in Cancer |
(Eng)
|
|
Tessitore A., Cicciarelli G., Mastroiaco V., Del Vecchio F., Capece D., Verzella D., Fischietti M., Vecchiotti D., Zazzeroni F., Alesse E.
|
| Vol 14, No 2 (2014) |
Therapeutic Vaccines Explored in Patients with Non-Small Cell Lung Cancer |
(Eng)
|
|
Ma K., Tang Y.
|
| Vol 24, No 9 (2024) |
Thiosemicarbazone-benzenesulfonamide Derivatives as Human Carbonic Anhydrases Inhibitors: Synthesis, Characterization, and In silico Studies |
(Eng)
|
|
Trawally M., Demir-Yazıcı K., Angeli A., Kaya K., Akdemir A., Supuran C., Güzel-Akdemir Ö.
|
| Vol 14, No 7 (2014) |
Three Amino Acid Derivatives of Valproic Acid: Design, Synthesis, Theoretical and Experimental Evaluation as Anticancer Agents |
(Eng)
|
|
Luna-Palencia G., Martinez-Ramos F., Vasquez-Moctezuma I., Fragoso-Vazquez M., Mendieta-Wejebe J., Padilla-Martínez I., Sixto-Lopez Y., Mendez-Luna D., Trujillo-Ferrara J., Meraz-Rios M., Fonseca-Sabater Y., Correa-Basurto J.
|
| Vol 16, No 11 (2016) |
To Analyze the Amelioration of Phenobarbital Induced Oxidative Stress by Erucin, as Indicated by Biochemical and Histological Alterations |
(Eng)
|
|
Arora R., Bhushan S., Kumar R., Mannan R., Kaur P., Singh B., Sharma R., Vig A., Singh B., Singh A., Arora S.
|
| Vol 13, No 7 (2013) |
Tocotrienols Target PI3K/Akt Signaling in Anti-Breast Cancer Therapy |
(Eng)
|
|
Sylvester P., Ayoub N.
|
| Vol 14, No 5 (2014) |
Tools For Decision-Making In Older Cancer Patients. Role Of The Comprehensive Geriatric Assessment |
(Eng)
|
|
Molina-Garrido M., Guillen-Ponce C., Castellano C., Errasquin B., Mora-Rufete A., Cruz-Jentoft A.
|
| Vol 10, No 9 (2010) |
Topoisomerase I Inhibitors in the Treatment of Primary CNS Malignancies: An Update on Recent Trends |
(Eng)
|
|
P. Sasine J., Savaraj N., G. Feun L.
|
| Vol 15, No 2 (2015) |
Toxic Effects of Aflatoxin B1 on Embryonic Development of Zebrafish (Danio rerio): Potential Activity of Piceatannol Encapsulated Chitosan/poly (Lactic Acid) Nanoparticles |
(Eng)
|
|
Dhanapal J., Ravindrran M., Baskar S.
|
| 1101 - 1200 of 1242 Items |
<< < 1 2 3 4 5 6 7 8 9 10 11 12 13 > >> |
